# Shanghai Dunwill Medical Technology Development Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-dunwill-medical-technology-development-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.dunwill.com
- Latest round: Series A (Jun 1, 2022)
- Investors on record: 5

## About

Founded in 2006 and based in Shanghai, China, Shanghai Dunwill Medical Technology Development Co., Ltd. is a medical technology company that focuses on the research and development of tumor and metabolic disease diagnostic products. The founder of the company is Dong Wen.

The company's main products include microRNA (miRNA) early diagnosis of liver cancer, circulating tumor cells (CTC) early warning of liver cancer metastasis and recurrence, and liver cancer patient-derived tissue transplantation models (PDX) to guide targeted therapy.

## Funding rounds

- Series A, Jun 1, 2022 — Cowin Capital, Shandong High-tech Investment Corporation, Funway Capital, Jiangsu Zhiyuan Capital Management, Qianhai Infrastructure Investment

## Investors

- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series A
- Shandong High-tech Investment Corporation (https://capitalatlas.ai/funds/shandong-high-tech-investment-corporation) — Series A
- Funway Capital (https://capitalatlas.ai/funds/funway-capital) — Series A
- Jiangsu Zhiyuan Capital Management — Series A
- Qianhai Infrastructure Investment — Series A